180 Wealth Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,282
Closed -$236K – 506
2026
Q2
$236K Buy
+2,282
New +$204K 0.02% 426
2026
Q1
– Sell
-2,671
Closed -$212K – 480
2025
Q4
$212K Buy
2,671
+15
+0.6% +$1.18K 0.02% 437
2025
Q3
$200K Buy
+2,656
New +$182K 0.02% 434
2024
Q2
– Sell
-3,248
Closed -$259K – 437
2024
Q1
$259K Sell
3,248
-19,967
-86% -$1.53M 0.05% 326
2023
Q4
$1.88M Buy
23,215
+41
+0.2% +$2.92K 0.38% 74
2023
Q3
$1.62M Buy
23,174
+1,376
+6% +$97.5K 0.36% 77
2023
Q2
$1.52M Buy
21,798
+112
+0.5% +$7.97K 0.33% 82
2023
Q1
$1.61M Sell
21,686
-2,919
-12% -$245K 0.37% 76
2022
Q4
$2.16M Buy
24,605
+786
+3% +$75.8K 0.51% 58
2022
Q3
$2.27M Buy
23,819
+1,695
+8% +$168K 0.63% 42
2022
Q2
$2.08M Sell
22,124
-208
-0.9% -$20.3K 0.53% 54
2022
Q1
$2.32M Buy
22,332
+18
+0.1% +$1.89K 0.51% 53
2021
Q4
$2.27M Buy
22,314
+173
+0.8% +$16K 0.51% 51
2021
Q3
$1.9M Buy
22,141
+434
+2% +$36.4K 0.42% 65
2021
Q2
$1.81M Sell
21,707
-2,992
-12% -$245K 0.41% 62
2021
Q1
$2.22M Buy
24,699
+666
+3% +$48.5K 0.55% 45
2020
Q4
$1.81M Buy
24,033
+902
+4% +$58.7K 0.52% 49
2020
Q3
$1.38M Buy
23,131
+3,350
+17% +$208K 0.52% 51
2020
Q2
$1.29M Buy
19,781
+201
+1% +$12.7K 0.51% 49
2020
Q1
$1.08M Buy
19,580
+1,640
+9% +$109K 0.56% 48
2019
Q4
$1.35M Buy
17,940
+1,883
+12% +$132K 0.54% 47
2019
Q3
$1.01M Buy
16,057
+1,716
+12% +$102K 0.45% 61
2019
Q2
$794K Buy
+14,341
New +$772K 0.36% 78
2018
Q3
– Sell
-17,888
Closed -$1.15M – 259
2018
Q2
$1.15M Buy
17,888
+2,565
+17% +$169K 0.57% 50
2018
Q1
$956K Buy
15,323
+5,199
+51% +$373K 0.5% 60
2017
Q4
$734K Buy
+10,124
New +$736K 0.37% 82

Other funds holding CVS

180 Wealth Advisors's CVS Position: Q3 2026 in Review

180 Wealth Advisors sold out of CVS Health (CVS) in Q3 2026, closing a stake of 2,282 shares — an estimated $236K sold.

180 Wealth Advisors first reported a position in CVS in Q4 2017 and held it in 26 quarters. The position peaked at $2.32M in Q1 2022. 1,998 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • 180 Wealth Advisors reported no remaining CVS Health position as of Q3 2026 after selling out during the quarter.
  • 180 Wealth Advisors sold 2,282 CVS Health shares in Q3 2026, an estimated $236K.
  • 180 Wealth Advisors first reported a position in CVS Health in Q4 2017 and held it in 26 quarters.
  • 180 Wealth Advisors's CVS Health position peaked at $2.32M in Q1 2022.
  • 1,998 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on 180 Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.